Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Neurologic Clinics
|
April 8, 2023
Autism in Women
Cesar Ochoa-Lubinoff, Bridget A Makol, Emily F Dillon
International Journal of Speech-Language Pathology
|
July 3, 2019
Screening school-age children for developmental language disorder in primary care
Kerry Danahy Ebert, Cesar Ochoa-Lubinoff, Melissa P Holmes
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
April 11, 2023
Health-related quality of life and medication use among individuals with Angelman syndrome
Nasreen Khan, Raquel Cabo, Rebecca D Burdine, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
September 9, 2023
An adapted clinical global Impression of improvement for use in Angelman syndrome: Validation analyses utilizing data from the NEPTUNE study
Pamela Ventola, Judith Jaeger, Christopher J Keary, et al.
American Journal of Medical Genetics. Part A
|
September 9, 2017
Pharmacological interventions to improve cognition and adaptive functioning in Down syndrome: Strides to date
Sarah J Hart, Jeannie Visootsak, Paul Tamburri, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
August 28, 2023
Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study
Christopher Keary, Lynne M Bird, Marie-Claire de Wit, et al.
Neurology
|
January 14, 2021
The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome
Lynne M Bird, Cesar Ochoa-Lubinoff, Wen-Hann Tan, et al.
Journal of Neurodevelopmental Disorders
|
July 26, 2023
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)
Jorrit Tjeertes, Carlos A Bacino, Terry Jo Bichell, et al.
Journal of Clinical Medicine
|
April 30, 2021
Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer's Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study
James A Hendrix, David C Airey, Angela Britton, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Neurologic Clinics
|
April 8, 2023
Autism in Women
Cesar Ochoa-Lubinoff, Bridget A Makol, Emily F Dillon
International Journal of Speech-Language Pathology
|
July 3, 2019
Screening school-age children for developmental language disorder in primary care
Kerry Danahy Ebert, Cesar Ochoa-Lubinoff, Melissa P Holmes
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
April 11, 2023
Health-related quality of life and medication use among individuals with Angelman syndrome
Nasreen Khan, Raquel Cabo, Rebecca D Burdine, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
September 9, 2023
An adapted clinical global Impression of improvement for use in Angelman syndrome: Validation analyses utilizing data from the NEPTUNE study
Pamela Ventola, Judith Jaeger, Christopher J Keary, et al.
American Journal of Medical Genetics. Part A
|
September 9, 2017
Pharmacological interventions to improve cognition and adaptive functioning in Down syndrome: Strides to date
Sarah J Hart, Jeannie Visootsak, Paul Tamburri, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
August 28, 2023
Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study
Christopher Keary, Lynne M Bird, Marie-Claire de Wit, et al.
Neurology
|
January 14, 2021
The STARS Phase 2 Study: A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome
Lynne M Bird, Cesar Ochoa-Lubinoff, Wen-Hann Tan, et al.
Journal of Neurodevelopmental Disorders
|
July 26, 2023
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)
Jorrit Tjeertes, Carlos A Bacino, Terry Jo Bichell, et al.
Journal of Clinical Medicine
|
April 30, 2021
Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer's Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study
James A Hendrix, David C Airey, Angela Britton, et al.
Page
of 1